Carotid endothelial shear stress reduction with aging is associated with plaque development in twelve years

Claudio Carallo1, Cesare Tripolino2, Maria Serena De Franceschi2

  • 1Metabolic Diseases Unit, Department of Clinical and Experimental Medicine, "Magna Græcia" University, Viale Europa, 88100, Catanzaro, Italy; Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, United Kingdom.

Atherosclerosis
|June 9, 2016
PubMed

Insights

Reduced endothelial shear stress with aging is a key predictor of atherosclerosis development. This finding highlights the importance of monitoring haemodynamic changes for cardiovascular disease prevention.

Area of Science:

  • Cardiovascular Science
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Atherosclerosis is linked to clinical, biochemical, and haemodynamic risk factors.
  • Evaluating carotid plaque development requires assessing haemodynamic profiles over time.

Purpose of the Study:

  • To assess carotid plaque development in relation to baseline and follow-up haemodynamic changes.
  • To identify haemodynamic predictors of atherosclerosis progression over 12 years.

Main Methods:

  • Echography used to evaluate and score atherosclerotic plaques in 48 participants.
  • Echo-Doppler computed endothelial shear stress, wall tension, arterial stiffness, and blood viscosity.
  • Logistic regression analyzed associations between atherosclerosis, risk factors, and haemodynamic variations.

Main Results:

  • Mean endothelial shear stress decreased, while wall tension and arterial stiffness increased over 12 years.
  • Carotid plaque scores significantly increased (p < 0.01).
  • Reduced shear stress with aging independently predicted carotid atherosclerosis (OR=0.94, p=0.01).

Conclusions:

  • Aging-related reduction in endothelial shear stress is an independent predictor of atherosclerosis.
  • Asymmetrical shear stress reduction correlated with increased plaque score on the affected side.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.9K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
915
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
569